Amphera is a late-stage biotechnology company developing cell therapies to treat cancer. MesoPher is comprised of autologous dendritic cells loaded with PheraLys, a lysate of tumour cell lines. PheraLys contains a broad repertoire of tumour-associated antigens, many of which are present in pancreatic cancer and other cancers.
View Top Employees from Amphera B.V.| Website | https://www.amphera.nl |
| Revenue | $5.8 million |
| Employees | 4 (0 on RocketReach) |
| Founded | 2012 |
| Phone | +31 73 627 4520 |
| Industry | Biotechnology, Business Services General, Discovery Tools (Healthcare), Business Services |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541713 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies |
Looking for a particular Amphera B.V. employee's phone or email?
Amphera B.V. Questions
The Amphera B.V. annual revenue was $5.8 million in 2024.
Amphera B.V. is based in 's-Hertogenbosch, Noord-Brabant.
The NAICS codes for Amphera B.V. are [54171, 54, 541713, 541, 5417].
The SIC codes for Amphera B.V. are [873, 87].
Related Companies
